Home Featured Page 174

Featured

Latest

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

2025 Year in Review: 10 Standout Stories in Psychedelics

2025 Year in Review: Looking Ahead to Psychedelics in 2026 (Video)

Oli Genn-Bash: Functional Mushrooms, Hype Cycles, and Mycelial Thinking

Numinus Wellness Inc. Reports Q2 2022 Results

PT313 – Christine Calvert, LCDC – Holotropic Breathwork, Ethics, and Dying...

Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial...

Filament Health and Psyence Enter into Exclusive Licensing Agreement for Natural...

Psychedelic Bulletin: Psychedelics X Big Pharma; $23m Round for At-Home Ketamine...

MYND Life Sciences Announces $3.5 Million Share Offering

Psychedelic Research Bulletin: March 2022

PT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere

COMPASS Pathways partners with One Mind to fund Rising Star Awards...

Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application...

1...173174175...305 Page 174 of 305

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

2025 Year in Review: 10 Standout Stories in Psychedelics

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

2025 Year in Review: 10 Standout Stories in Psychedelics

2025 Year in Review: Looking Ahead to Psychedelics in 2026 (Video)

Oli Genn-Bash: Functional Mushrooms, Hype Cycles, and Mycelial Thinking

Numinus Wellness Inc. Reports Q2 2022 Results

PT313 – Christine Calvert, LCDC – Holotropic Breathwork, Ethics, and Dying...

Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial...

Filament Health and Psyence Enter into Exclusive Licensing Agreement for Natural...

Psychedelic Bulletin: Psychedelics X Big Pharma; $23m Round for At-Home Ketamine...

MYND Life Sciences Announces $3.5 Million Share Offering

Psychedelic Research Bulletin: March 2022

PT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere

COMPASS Pathways partners with One Mind to fund Rising Star Awards...

Mindset Pharma Strengthens IP Portfolio with Another New Provisional Patent Application...

EDITOR PICKS

Manvir Singh: Shamanism, the Timeless Religion

2025 Year in Review: Future(s) & Open Questions (Video)

2025 Year in Review: 10 Standout Stories in Psychedelics

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY